Latest News and Press Releases
Want to stay updated on the latest news?
-
GRF manipulates reported debt & EBITDA to artificially reduce reported leverage to 6x which we believe is closer to 10x-13x
-
NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Grifols, S.A....
-
NEW YORK, Jan. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Grifols, S.A....
-
NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Grifols, S.A....
-
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Grifols,...
-
We are investigating whether Grifols, S.A. has violated federal securities laws based on allegations in a report by Gotham City Research.
-
BOSTON, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Grifols S.A. ADR (NASDAQ: GRFS) for potential securities law violations. Investors who have lost money in their Grifols...
-
Covina, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The protein which blocks thrombin is called as antithrombin. Antithrombin is the glycoprotein which is synthesized by the liver. Antithrombin inhibits the...